PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit

The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.